2006
DOI: 10.1111/j.1600-0625.2006.00391.x
|View full text |Cite
|
Sign up to set email alerts
|

Delineation of diversified desmoglein distribution in stratified squamous epithelia: implications in diseases

Abstract: Desmogleins play critical roles in cell adhesion and skin blistering diseases, as they are the target antigens of autoimmune antibodies and bacterial toxins. We recently cloned several novel members of the desmoglein gene family, bringing the number of desmogleins to four in the rat and human genomes and six in the mouse. Here, we have produced a monoclonal antibody to a cytoplasmic epitope of Dsg4, assessed its specificity and compared it to several existing Dsg1-3 antibodies. We also demonstrated cross-react… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
80
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
3
2
2

Relationship

1
6

Authors

Journals

citations
Cited by 70 publications
(85 citation statements)
references
References 40 publications
(43 reference statements)
5
80
0
Order By: Relevance
“…Because incubation with PF-IgG (containing Dsg 1-specific autoantibodies only) led to keratinocyte dissociation and epidermal splitting, these results demonstrate that Dsg 3 in these models does not compensate for the functional loss of Dsg 1. Our results on the distribution patterns of Dsg 1 and Dsg 3 in human epidermis are supported by a recent study by Mahoney et al, 19 who also found that Dsg 1 and Dsg 3 broadly overlap in the epidermis and that restriction of Dsg 1 to the superficial epidermis and of Dsg 3 to the basal layer is only observed in mouse but not human epidermis. All these data suggest that the clinical phenotype of PV and PF in humans may not be explained by the distribution patterns of Dsg 1 and Dsg 3 alone.…”
Section: Dsg 3 Does Not Compensate For Dsg 1 In Human Epidermissupporting
confidence: 79%
See 1 more Smart Citation
“…Because incubation with PF-IgG (containing Dsg 1-specific autoantibodies only) led to keratinocyte dissociation and epidermal splitting, these results demonstrate that Dsg 3 in these models does not compensate for the functional loss of Dsg 1. Our results on the distribution patterns of Dsg 1 and Dsg 3 in human epidermis are supported by a recent study by Mahoney et al, 19 who also found that Dsg 1 and Dsg 3 broadly overlap in the epidermis and that restriction of Dsg 1 to the superficial epidermis and of Dsg 3 to the basal layer is only observed in mouse but not human epidermis. All these data suggest that the clinical phenotype of PV and PF in humans may not be explained by the distribution patterns of Dsg 1 and Dsg 3 alone.…”
Section: Dsg 3 Does Not Compensate For Dsg 1 In Human Epidermissupporting
confidence: 79%
“…4,16 However, recent studies indicate that the expression patterns of Dsg 1 and Dsg 3 in mice profoundly differ from those in humans. 19 iv) To visualize the desmoglein localization pattern in human epidermis, autoantibodies from patients with PV and PF have been applied. 15,20 In these studies, either whole sera of PV and PF patients were used without characterization of the autoantibody profile 20 or IgG fractions were used after immunosabsorption with recombinant Dsg extracellular domains fused to the Fc portion of human IgG.…”
mentioning
confidence: 99%
“…For immunofluorescence, OCT-fixed tissue sections (5 pm) were prepared as previously described (Mahoney et al, 2006) with DAPI (100 ng/ml) for DNA counterstaining. OCT-fixed tissues were used with the following antibodies: Flag, MP6, CK6, CK10, 23F4, 1 1E4, and (3-catenin.…”
Section: Immunoblotting and Immunohistochemistrymentioning
confidence: 99%
“…Four distinct desmogleins (Dsgl-4) have been reported with differential expression profiles dependent on the tissue type and differentiation state (Cheng and Koch, 2004;Garrod et al, 2002;Mahoney et al, 2006). Unlike Dsgl and Dsg3 whose expression is restricted to complex stratified epithelia, Dsg2 and Dsg4 are expressed in a wide range of other cell types.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation